Skip to content
Open access

Clinical and neurobiological correlates of tardive dyskinesia in schizophrenia spectrum disorders and mood disorders

Aug 2026 · Schizophrenia · Vol 12 · 0 citations · 101 references
Medicine

TL;DR

It is suggested that TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.

Abstract

Tardive dyskinesia (TD) is a persistent sensorimotor syndrome associated with antipsychotic exposure in schizophrenia spectrum disorders (SSD) and mood disorders (MOD), yet its neurobiological basis remains poorly understood. We investigated whether TD represents a distinct clinical and neurobiological phenotype across SSD and MOD. In this study, we examined a bicentric cohort of 453 individuals with SSD (n = 360) or MOD (n = 93), including early-psychosis (EP) and multiple-episode SSD patients. TD status was defined using Schooler and Kane criteria based on the Abnormal Involuntary Movement Scale (AIMS). Psychopathology was assessed with the Positive and Negative Syndrome Scale (PANSS). Structural MRI data were processed using FreeSurfer (v7.4.1). Propensity score matching was applied to compare TD-positive and TD-negative patients while controlling for age, sex, illness duration, antipsychotic dose, and PANSS scores. TD prevalence was 10.6% in multiple-episode SSD (n = 31) and 7.5% in MOD (n = 7), whereas no EP patients met criteria for TD. Logistic regression identified male sex (p = 0.005) and higher PANSS general psychopathology scores (p = 0.021) as independent predictors of TD. TD-positive patients showed reduced paracentral cortical surface area in both the matched SSD sample (n = 86; p = 0.006, corr.) and the combined transdiagnostic sample (n = 179; p = 0.024, corr.). These alterations were absent in EP patients. In conclusion, our findings suggest that TD is a transdiagnostic phenomenon, occurring in both SSD and MOD. However, TD in SSD appears to be associated with a distinct clinical and neurobiological phenotype, marked by greater illness severity, male predominance, and focal sensorimotor cortical alterations.

Read PDF

Similar papers

Aug 2026

Cognitive impairment in catatonia compared to other psychiatric disorders.

INTRODUCTION Catatonia is a neuropsychiatric syndrome associated with cognitive impairments, yet the neurocognitive performance of catatonia relative to other psychiatric disorders is poorly understood. This study characterised neurocognitive profiles in patients with a history of catatonia compared to schizophrenia sp...

Joseph M. Bianco, Joseph J. Cooper, Victor A. Valencia et al. · 0 citations
Open access Sep 2026

Parkinsonism and psychopathology severity in real-world outpatients with schizophrenia: A cross-sectional PRISM study.

Extrapyramidal symptoms (EPS) have been described as intrinsic to schizophrenia spectrum disorders (SSD), beyond medication-induced effects. Among EPS, parkinsonism is the most prevalent subtype and has been linked to poorer clinical and functional outcomes. We aimed to examine the relationships between parkinsonism an...

Joaquín Galvañ, J. López-Moríñigo, Gonzalo Salazar de Pablo et al. · 0 citations
Open access Sep 2026

Cenobamate Improves Emotional Dysregulation, Impulsivity, and Apathy in Drug-Resistant Focal Epilepsy: A Longitudinal Neuropsychological Study.

INTRODUCTION Although effects on cognitive function have been reported during cenobamate (CNB) treatment, far less is known about how it may affect neuropsychological domains such as apathy, emotion dysregulation, and impulsivity. This prospective longitudinal study aims to assess psychopathological and cognitive chang...

I. Sammarra, Adriana Saraceno, Iolanda Martino et al. · 0 citations
Open access Sep 2026

Fenfluramine in Rett syndrome: A multidimensional clinical study

Fenfluramine was associated with clinically meaningful improvements across several symptom domains in patients with RTT, including seizures, respiratory dysfunction, behavior, sleep, and overall disease severity, with an acceptable safety profile.

E. González-Alguacil, Nuria Lamagrande Casanova, Manuel Luján-Bonete et al. · 0 citations
Open access Sep 2026

637. Executive functions in neurodevelopmental disorders: evidence of a cognitive continuum between autism and schizophrenia

The observed pattern of impairment is consistent with that described in chronic schizophrenia and clinical high-risk states for psychosis, confirming that these domains are frequently altered along the continuum of Neurodevelopmental Syndromes (NDS).

C. Ceparano, F. Iannotta, C. Ricci et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.